Clinical Trials Browser

Completed × OTHER × Parkinson Disease 4, Autosomal Dominant Lewy Body × Clear all

Pyridoxine-dependent epilepsy, Parkinson Disease 4, Autosomal Dominant Lewy Body, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Esophageal Neoplasms, Head and Neck Neoplasms, Mouth Neoplasms, Neoplasm Metastasis, Neoplasms

NCT04116073 2025-07-29

INCMGA00012 in Patients With Previously Treated Unresectable or Metastatic Adenosquamous Pancreatic or Ampullary Cancer

Phase 2 Completed

25 enrolled 12 charts

Parkinson Disease 4, Autosomal Dominant Lewy Body

NCT06900686 2025-03-28

Clinical Application of PD-1 Inhibitor in Colorectal Cancer for Improving Survival

Completed

458 enrolled

Gastrointestinal

Parkinson Disease 4, Autosomal Dominant Lewy Body, Colonic Neoplasms, Rectal Neoplasms

NCT02834052 2024-06-07

Pembrolizumab + Poly-ICLC in MRP Colon Cancer

Phase 1/2 Completed

42 enrolled 13 charts

Gastrointestinal

Parkinson Disease 4, Autosomal Dominant Lewy Body, Colonic Neoplasms

NCT02735239 2024-03-22

Study of Anti-PD-L1 in Combination With Chemo(Radio)Therapy for Oesophageal Cancer

Phase 1/2 Completed

73 enrolled 18 charts

Gastrointestinal

Adenocarcinoma Of Esophagus, Diabetes Mellitus, Insulin-Dependent, 12, Parkinson Disease 4, Autosomal Dominant Lewy Body, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT04271384 2023-12-26

Stereotactic Ablative Radiotherapy With Nivolumab for Early-Stage Operable Non-Small Cell Lung Cancer

Phase 2 Completed

25 enrolled

Thoracic

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Non-Small-Cell Lung

NCT02968940 2022-06-29

Avelumab With Hypofractionated Radiation Therapy in Adults With Isocitrate Dehydrogenase (IDH) Mutant Glioblastoma

Phase 2 Completed

6 enrolled 10 charts

CNS

Parkinson Disease 4, Autosomal Dominant Lewy Body, Glioblastoma, Glioma

NCT02549209 2022-03-02

Pembro/Carbo/Taxol in Endometrial Cancer

Phase 2 Completed

46 enrolled 13 charts

Gynecologic

Parkinson Disease 4, Autosomal Dominant Lewy Body, Endometrial Neoplasms

NCT02983006 2021-10-18

Study of DS-8273a With Nivolumab in Unresectable Stage III or Stage IV Melanoma

Phase 1 Completed

12 enrolled

Dermatologic

Parkinson Disease 4, Autosomal Dominant Lewy Body, Melanoma

Clinical Trials

Tadalafil and Pembrolizumab in Recurrent or Metastatic Head and Neck Cancer

INCMGA00012 in Patients With Previously Treated Unresectable or Metastatic Adenosquamous Pancreatic or Ampullary Cancer

Clinical Application of PD-1 Inhibitor in Colorectal Cancer for Improving Survival

Pembrolizumab + Poly-ICLC in MRP Colon Cancer

Study of Anti-PD-L1 in Combination With Chemo(Radio)Therapy for Oesophageal Cancer

Stereotactic Ablative Radiotherapy With Nivolumab for Early-Stage Operable Non-Small Cell Lung Cancer

Avelumab With Hypofractionated Radiation Therapy in Adults With Isocitrate Dehydrogenase (IDH) Mutant Glioblastoma

Pembro/Carbo/Taxol in Endometrial Cancer

Study of DS-8273a With Nivolumab in Unresectable Stage III or Stage IV Melanoma